Technology

Agile Therapeutics

$3.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (+2.04%) Today
+$0.09 (+3.00%) As of 11:04 AM UTC after-hours

Why Robinhood?

You can buy or sell AGRX and other stocks, options, and ETFs commission-free!

About AGRX

Agile Therapeutics, Inc. Common Stock, also called Agile Therapeutics, is a healthcare company, which engages in the development and commercialization of transdermal patch. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ. The listed name for AGRX is Agile Therapeutics, Inc. Common Stock.

CEO
Alfred F. Altomari
Employees
15
Headquarters
Princeton, New Jersey
Founded
1997
Market Cap
265.48M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.17M
High Today
$3.01
Low Today
$2.85
Open Price
$2.92
Volume
2.33M
52 Week High
$4.77
52 Week Low
$1.35

Collections

AGRX Earnings

-$0.18
-$0.12
-$0.06
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 18, After Hours

You May Also Like

SPEM
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure